| Date Filed | Type | Description |
| 09/26/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/22/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 08/22/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
4
| SKARVAN KATHLEEN (Director) has filed a Form 4 on Electromed, Inc.|
Txns:
| Sold 1,107 shares
@ $10.8325, valued at
$12k
|
|
| 07/05/2023 |
4
| Nagel Bradley M. (CFO) has filed a Form 4 on Electromed, Inc.|
Txns:
| Granted 6,600 shares
@ $0
Granted 7,900 options to buy
@ $10.71, valued at
$84.6k
|
|
| 07/05/2023 |
4
| Cunniff James L. (CEO and President) has filed a Form 4 on Electromed, Inc.|
Txns:
| Granted 175,000 options to buy
@ $10.71, valued at
$1.9M
Granted 87,500 rights
@ $0 |
|
| 07/05/2023 |
3
| Cunniff James L. (CEO and President) has filed a Form 3 on Electromed, Inc. |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/06/2023 |
4
| SKARVAN KATHLEEN (President and CEO) has filed a Form 4 on Electromed, Inc.|
Txns:
| Paid exercise price by delivering 24,815 shares
@ $13.5, valued at
$335k
Gifted 40,185 shares
@ $0
Exercised 15,000 options to buy
@ $1.31, valued at
$19.7k
Exercised 50,000 options to buy
@ $1.4, valued at
$70k
|
|
| 02/14/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| Radoff Bradley Louis reports a 7.3% stake in Electromed, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
8-K
| Quarterly results |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/08/2022 |
8-K
| Quarterly results |
| 11/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/24/2022 |
8-K
| Quarterly results |
| 09/27/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/27/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/14/2022 |
4
| SKARVAN KATHLEEN (President and CEO) has filed a Form 4 on Electromed, Inc.|
Txns:
| Paid exercise price by delivering 8,240 shares
@ $11.46, valued at
$94.4k
Gifted 11,760 shares
@ $0
Exercised 20,000 options to buy
@ $1.75, valued at
$35k
|
|
| 08/23/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
| 08/23/2022 |
8-K
| Quarterly results |
|